FOR IMMEDIATE RELEASE
Breast Cancer Non-Profit Funds Promising New Clinical Trial
The Laurus Project, a breast cancer non-profit organization, announced a new research grant to Dr. Linda Vahdat, Medical Oncologist at Memorial Sloan Kettering Cancer Center Breast Cancer Research Program. In an initial clinical trial of triple negative breast cancer patients organized by Dr. Vahdat, close to 82% had no detectable cancer at a five-year follow-up.
Numerous studies have confirmed that cancer cells can lay dormant for years, waiting for a signal to trigger growth. Copper has been shown to be crucial in activating the dormant cells. The clinical trial run by Dr. Vahdat focused on depleting copper in levels in patients’ blood, creating an environment biologically hostile to tumor growth. The research grant will be used to fund a randomized phase II trial.
“Dr. Vahdat’s research may point to a new way of treating breast cancer,” said Teresa Lawsky, Founder and CEO of The Laurus Project. “By targeting the cancer microenvironment, she has found an innovative way to keep patients in remission.”
About The Laurus Project
Founded in 2015, The Laurus Project is a not-for-profit that focuses on breast cancer prevention, treatment and quality of life for survivors. By supporting mission aligned scientists, doctors and programs in their formative efforts as they search for new pathways in breast disease and identify targeted modes of therapy, The Laurus Project aims to save and empower individuals affected by breast cancer.
Congratulations to Dr. Vahdat. She is so deserving of this award. As participant in the trial I know first hand how hard she works. She is determined, intelligent, compassionate and most of all full of kindness. Thank you to The Laurus Project. This is a major breakthrough in cancer research.
Mary Hill